Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
What Are Best Practices in Literature Monitoring for Top-performing Pharma Companies?
Posted on June 14th, 2017 by Betsy Davis in Pharmacovigilance
The health and safety of patients is of utmost concern to pharmaceutical companies, and strict regulatory requirements ensure that safety standards remain high. But pharmacovigilance becomes an ever more difficult and overwhelming practice Continue reading “What Are Best Practices in Literature Monitoring for Top-performing Pharma Companies?” »
Gaining the Competitive Advantage
Posted on June 12th, 2017 by Christine de Vries - Scheidegger in Pharma R&D
It cannot be overstated how important it is for pharmaceutical companies to get new drugs to market as fast as possible. That some of these drugs could actually be life-saving, or at least life-altering, for hundreds, thousands or even millions of potential patients Continue reading “Gaining the Competitive Advantage” »
Overcoming Resistance to Precision Medicines
Posted on May 10th, 2017 by Betsy Davis in Pharma R&D
Precision medicines, which target specific subgroups of patients bearing particular mutations or symptoms, have demonstrated astounding efficacies and have had great success in areas with limited treatment options. Continue reading “Overcoming Resistance to Precision Medicines” »
Targeting Rare Diseases
Posted on March 20th, 2017 by Sherry Winter in Pharma R&D
What is known as a “rare” disease might affect anywhere between a couple hundred to a couple hundred thousand people here in the U.S. And it’s estimated that as much as 10% of the nation’s population has one of the thousands of known rare diseases, most of which are genetic. Continue reading “Targeting Rare Diseases” »
